-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Scinai Immunotherapeutics Ltd. annual/quarterly Operating Income (Loss) history and growth rate from 2021 to 2023.
- Scinai Immunotherapeutics Ltd. Operating Income (Loss) for the quarter ending June 30, 2023 was -$2.6M, a 20.5% increase year-over-year.
- Scinai Immunotherapeutics Ltd. annual Operating Income (Loss) for 2023 was $9.71M.
- Scinai Immunotherapeutics Ltd. annual Operating Income (Loss) for 2022 was -$11.1M, a 1.83% decline from 2021.
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)